Pharmicell Ltd.

Pharmicell Ltd., Korea’s biopharma pioneer, develops autologous stem‑cell therapeutics (Cellgram_AMI, LC, ED, CKD) and manufacturing intermediates. With a global pipeline and in‑house stem‑cell bank, the company targets high‑growth regenerative markets.

Headquarters: South Korea (KOR)

Pharmicell Ltd. Logo
Company Profile
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
005690 Pharmicell Ltd.
Cap: 830.5B
EQUITY KSC KRW KR7005690003 Active
📈
Home Login